973
Views
20
CrossRef citations to date
0
Altmetric
Perspective

Resistance is not futile: treatment-refractory schizophrenia – overview, evaluation and treatment

&
Pages 11-24 | Received 30 Aug 2018, Accepted 30 Oct 2018, Published online: 08 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Mikkel Højlund & Christoph U. Correll. (2023) Switching to long-acting injectable antipsychotics: pharmacological considerations and practical approaches. Expert Opinion on Pharmacotherapy 24:13, pages 1463-1489.
Read now
Meghan Musselman, Eric Huynh, Rachana Kelshikar, Eric Lee, Mohammed Malik & Justin Faden. (2023) Potassium channel modulators and schizophrenia: an overview of investigational drugs. Expert Opinion on Investigational Drugs 32:6, pages 471-477.
Read now
Justin Faden, Ryan Serdenes & Leslie Citrome. (2022) Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?. Expert Review of Neurotherapeutics 22:5, pages 365-376.
Read now
Justin Faden, Natasha Kiryankova-Dalseth, Ruby Barghini & Leslie Citrome. (2021) Does antipsychotic combination therapy reduce the risk of hospitalization in schizophrenia?. Expert Opinion on Pharmacotherapy 22:5, pages 635-646.
Read now

Articles from other publishers (16)

Xiujun Zhang, Muhammad Jawwad Saif, Nazeran Idrees, Salma Kanwal, Saima Parveen & Fatima Saeed. (2023) QSPR Analysis of Drugs for Treatment of Schizophrenia Using Topological Indices. ACS Omega 8:44, pages 41417-41426.
Crossref
Vjekoslav Peitl, Antonia Puljić, Mislav Škrobo, Sergej Nadalin, Lidija Fumić Dunkić & Dalibor Karlović. (2023) Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia. Biomedicines 11:4, pages 1072.
Crossref
Umme Habiba, Aafia Malik, Ghazala Kaukab Raja, Muhammad Raza Memon, Asad Tameezud din Nizami, Rafaqat Ishaq, Muhammad Ilyas, Hadi Valadi, Muhammad Nawaz & Pakeeza Arzoo Shaiq. (2023) Differential Treatment Responses in Pakistani Schizophrenia Samples: Correlation with Sociodemographic Parameters, Drug Addiction, Attitude to the Treatment and Antipsychotic Agents. Brain Sciences 13:3, pages 407.
Crossref
A.N. Pomytkin, D.V. Tikhonov & V.G. Kaleda. (2023) Augmentation therapy of resistant schizophrenia with rhythmic transcranial magnetic stimulation. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 123:8, pages 107.
Crossref
Justin Faden & Leslie Citrome. (2023) Schizophrenia: One Name, Many Different Manifestations. Medical Clinics of North America 107:1, pages 61-72.
Crossref
Subho Chakrabarti. (2021) Clozapine resistant schizophrenia: Newer avenues of management. World Journal of Psychiatry 11:8, pages 429-448.
Crossref
Steven Berendsen, Henricus L. Van, Jasper W. van der Paardt, Olav R. de Peuter, Marion van Bruggen, Hans Nusselder, Margje Jalink, Jaap Peen, Jack J. M. Dekker & Lieuwe de Haan. (2020) Exploration of symptom dimensions and duration of untreated psychosis within a staging model of schizophrenia spectrum disorders. Early Intervention in Psychiatry 15:3, pages 669-675.
Crossref
Mohsen Khosravi. (2021) Ursodeoxycholic Acid in Patients With Treatment-Resistant Schizophrenia Suffering From Coronavirus Disease 2019: A Hypothesis Letter. Frontiers in Psychiatry 12.
Crossref
Anas Ahmadi. (2021) The Traces of Oppression and Trauma to Ethnic Minorities in Indonesia Who Experienced Rape on the 12 May 1998 Tragedy: A Review of Literature. Journal of Ethnic and Cultural Studies 8:2, pages 126-144.
Crossref
Mu-Chun Lin & Hsing-Kang Chen. (2021) Psychotropic drug prescription patterns and their predictors among older adult patients with schizophrenia in a tertiary-referral psychiatric hospital. Taiwanese Journal of Psychiatry 35:2, pages 70.
Crossref
Nemanja N. Muric, Nebojsa N. Arsenijevic & Milica M. Borovcanin. (2020) Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment. Frontiers in Psychiatry 11.
Crossref
Peter F. Buckley. (2020) Treatment-Resistant Schizophrenia. FOCUS 18:4, pages 364-367.
Crossref
. (2020) Progress in Schizophrenia Research and Treatment. FOCUS 18:4, pages 440-442.
Crossref
Lennart Kyllesø, Robert Løvsletten Smith, Øystein Karlstad, Ole A. Andreassen & Espen Molden. (2020) Undetectable or subtherapeutic serum levels of antipsychotic drugs preceding switch to clozapine. npj Schizophrenia 6:1.
Crossref
Bruno B. Ortiz, Cinthia H. Higuchi, Cristiano Noto, Dan W. Joyce, Christoph U. Correll, Rodrigo A. Bressan & Ary Gadelha. (2020) A symptom combination predicting treatment-resistant schizophrenia – A strategy for real-world clinical practice. Schizophrenia Research 218, pages 195-200.
Crossref
Chunhui Wu, Yu Wang, Feipu Yang, Wenqiang Shi, Zhen Wang, Ling He, Yang He & Jingshan Shen. (2019) Synthesis and Biological Evaluation of Five‐Atom‐Linker‐Based Arylpiperazine Derivatives with an Atypical Antipsychotic Profile. ChemMedChem 14:24, pages 2042-2051.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.